Click for best price
Blood Cancer Therapeutics Market Size, Share 2022
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.
This report contains market size and forecasts of Blood Cancer Therapeutics in Global, including the following market information:
Global Blood Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Blood Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chronic Myeloid Leukemia (CML) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blood Cancer Therapeutics include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blood Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Chronic Myeloid Leukemia (CML)
Acute Lymphocytic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Global Blood Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Global Blood Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Blood Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Blood Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Novartis
Boehringer Ingelheim
Pfizer
Sanofi
| Report Attributes |
Report Details |
| Report Title |
Blood Cancer Therapeutics Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Blood Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Cancer Therapeutics Overall Market Size
2.1 Global Blood Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Blood Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Cancer Therapeutics Players in Global Market
3.2 Top Global Blood Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Blood Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Blood Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Blood Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Blood Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Blood Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Chronic Myeloid Leukemia (CML)
4.1.3 Acute Lymphocytic Leukemia (ALL)
4.1.4 Chronic Lymphocytic Leukemia (CLL)
4.1.5 Acute Myeloid Leukemia (AML)
4.2 By Type - Global Blood Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Blood Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Blood Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.2 By Application - Global Blood Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Blood Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Blood Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Blood Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Blood Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Blood Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Blood Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Blood Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Blood Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Blood Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Blood Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Blood Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Blood Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Blood Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Blood Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Blood Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Blood Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Blood Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Blood Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Blood Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Blood Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Blood Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Blood Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Blood Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Blood Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Blood Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Blood Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Blood Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Blood Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Blood Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Blood Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Blood Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Blood Cancer Therapeutics Major Product Offerings
7.1.4 AbbVie Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Blood Cancer Therapeutics Major Product Offerings
7.2.4 AstraZeneca Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Blood Cancer Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Blood Cancer Therapeutics Major Product Offerings
7.5.4 Roche Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Blood Cancer Therapeutics Major Product Offerings
7.6.4 Novartis Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Major Product Offerings
7.7.4 Boehringer Ingelheim Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Blood Cancer Therapeutics Major Product Offerings
7.8.4 Pfizer Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Pfizer Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Blood Cancer Therapeutics Major Product Offerings
7.9.4 Sanofi Blood Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Sanofi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Blood Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Blood Cancer Therapeutics Market Drivers in Global Market
Table 3. Blood Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Blood Cancer Therapeutics in Global Market
Table 5. Top Blood Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Blood Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Blood Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Blood Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Blood Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Blood Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Blood Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Blood Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Blood Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Blood Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Blood Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Blood Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Blood Cancer Therapeutics Product Offerings
Table 32. AbbVie Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Blood Cancer Therapeutics Product Offerings
Table 35. AstraZeneca Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Blood Cancer Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Blood Cancer Therapeutics Product Offerings
Table 41. GlaxoSmithKline Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Blood Cancer Therapeutics Product Offerings
Table 44. Roche Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Blood Cancer Therapeutics Product Offerings
Table 47. Novartis Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim Corporate Summary
Table 49. Boehringer Ingelheim Blood Cancer Therapeutics Product Offerings
Table 50. Boehringer Ingelheim Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Blood Cancer Therapeutics Product Offerings
Table 53. Pfizer Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Blood Cancer Therapeutics Product Offerings
Table 56. Sanofi Blood Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Blood Cancer Therapeutics Segment by Type in 2021
Figure 2. Blood Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Blood Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Blood Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Blood Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blood Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Blood Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Blood Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi Blood Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
